Basel Medical GroupBMGL
13F holders, Q1 2026 (March 31)4holders −6
1new positions
7sold out
$0.60avg. 13F price*
At the end of Q1 2026, 4 institutions reported holding Basel Medical Group Ltd. (BMGL) in their 13F filings, down 6 from Q4 2025. 1 opened new positions and 7 sold out. The largest holders were XTX Topco Ltd ($16K), T3 Companies, LLC ($9K) and UBS Group AG ($8K).
- Company
- Basel Medical Group Ltd.
- CUSIP
- G0864B103
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $9K |
| Exits | 7 | $51K |
All 13F filers, Q4 2025 → Q1 2026: 19,967 shares bought and 109,376 shares sold, net −89,409 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| XTX Topco Ltd | 0.00% | Reduce -15.4% | 25,756 | $16K |
| T3 Companies, LLC | 0.01% | New | 15,000 | $9K |
| UBS Group AG | 0.00% | Add +61.4% | 13,056 | $8K |
| Coston, McIsaac & Partners | 0.00% | No change | 50 | $0 |
"% of holder's portfolio" is BMGL's weight in each manager's 13F, not the share of Basel Medical Group Ltd. the manager owns.